Clinical development accelerator Quotient Sciences and CRO Lindus Health are joining forces to create a streamlined process for clients to advance from first-in-human (FIH) up to pivotal trials. The ...

Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and streamlined pathways for clinical trials. The partnership will address the ...

BOSTON, Dec.16, 2025 – Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, and Quotient Sciences, a leading global clinical development and ...

Venture Capital firm India Quotient has a proven blueprint for seed-stage investments in startups. As it endeavours to write a startup’s first cheque, it comes on board as early as possible and ...

India Quotient was the first investor in ShareChat, Sugar Cosmetics, Lendingkart, Kuku FM, Vyapar, and several other startups. India Quotient, an early-stage investor, has raised $129 million in its ...

With the fund, India Quotient aims to back pre-seed, seed stage Indian startups along with investing in idea stage startups Vice president Sahil Makkar and ex-Upside AI cofounder Kanika Agarrwal have ...

India Quotient, a Bengaluru-based early-stage venture capital firm, has made the final close of its fifth fund at $129 million (around Rs 1,132 crore), marking its largest fundraise to date. The new ...

NOTTINGHAM, UK—OCTOBER 14, 2025: Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (CRO), today ...

Sherre DeMao is CEO of BizGrowth Inc., a strategy, training and IP development firm focused on growing entrepreneurial enterprise value. “Too big to fail” was a term used during the Great Recession ...

Quotient Sciences and CPI have signed a memorandum of understanding to form a joint venture focused on accelerating RNA-based drug development. The collaboration will integrate both companies’ ...

The JV will combine Quotient Sciences' Translational Pharmaceutics® platform with CPI's expertise in small scale manufacture of RNA and LNP encapsulation to deliver a first-of-its-kind, integrated ...

MELBOURNE, AUSTRALIA / ACCESS Newswire / May 14, 2025 / With geopolitical tensions, inflation uncertainty, and global capital flows still shifting in response to the Trump administration's renewed ...